Changes in the Epidemiology of Pneumococcal Bacteremia in a Swiss University Hospital during a 15-Year Period, 1986-2000

Mayo Clinic Proceedings

Volumn 79, Issue 5, 2004, Pages 604-612

  Trampuz, Andrej ^a,c   Widmer, Andreas F ^a   Fluckiger, Ursula ^a   Haenggi, Monika ^a   Frei, Reno ^a   Zimmerli, Werner ^b  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b KANTONSSPITAL LIESTAL   (Switzerland)

^c MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PENICILLIN DERIVATIVE;

ADULT; AGED; AIR TEMPERATURE; BACTEREMIA; BLOOD CULTURE; CORONARY ARTERY DISEASE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION SENSITIVITY; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; RESPIRATORY TRACT INFECTION; REVIEW; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; SURVIVAL; SWITZERLAND; UNIVERSITY HOSPITAL;

EID: 2342448537     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/79.5.604     Document Type: Article

References (47)

1. Musher DM. Infections caused by Streptococcus pneumoniae: clinical spectrum, pathogenesis, immunity, and treatment. Clin Infect Dis. 1992;14:801-807.
2. Afessa B, Greaves WL, Frederick WR. Pneumococcal bacteremia in adults: a 14-year experience in an inner-city university hospital. Clin Infect Dis. 1995;21:345-351.
3. Plouffe JF, Breiman RF, Facklam RR, Franklin County Pneumonia Study Group. Bacteremia with Streptococcus pneumoniae: implications for therapy and prevention. JAMA. 1996;275:194-198.
4. Pastor P, Medley F, Murphy TV. Invasive pneumococcal disease in Dallas County, Texas: results from population-based surveillance in 1995. Clin Infect Dis. 1998;26:590-595.
5. Austriam R, Gold J. Pneumococcal bacteremia with especial reference to bacteremic pneumococcal pneumonia. Ann Intern Med. 1964;60:759-776.
6. Mufson MA, Stanek RJ. Bacteremic pneumococcal pneumonia in one American City: a 20-year longitudinal study, 1978-1997. Am J Med. 1999;107:34S-43S.
7. Farinas-Alvarez C, Farinas MC, Garcia-Palomo JD, et al. Prognostic factors for pneumococcal bacteremia in a university hospital. Eur J Clin Microbiol Infect Dis. 2000;19:733-741.
8. Karstaedt AS, Khoosal M, Crewe-Brown HH. Pneumococcal bacteremia in adults in Soweto, South Africa, during the course of a decade. Clin Infect Dis. 2001;33:610-614.
9. Laurichesse H, Romaszko JP, Nguyen LT, et al. Clinical characteristics and outcome of patients with invasive pneumococcal disease, Puy-de-Dome, France, 1994-1998. Eur J Clin Microbiol Infect Dis. 2001;20:299-308.
10. Turett GS, Blum S, Fazal BA, Justman JE, Telzak EE. Penicillin resistance and other predictors of mortality in pneumococcal bacteremia in a population with high human immunodeficiency virus seroprevalence. Clin Infect Dis. 1999;29;321-327.
11. Hirschtick RE, Glassroth J, Jordan MC, et al, Pulmonary Complications of HIV Infection Study Group. Bacterial pneumonia in persons infected with the human immunodeficiency virus. N Engl J Med. 1995;333:845-851.
12. Gebo KA, Moore RD, Keruly JC, Chaisson RE, Risk factors for pneumococcal disease in human immunodeficiency virus-infected patients. J Infect Dis. 1996;173;857-862.
13. Frankel RE, Virata M, Hardalo C, Altice FL, Friedland G. Invasive pneumococcal disease: clinical features, serotypes, and antimicrobial resistance patterns in cases involving patients with and without human immunodeficiency virus infection. Clin Infect Dis. 1996;23:577-584.
14. Feldman C, Glatthaar M, Morar R, et al. Bacteremic pneumococcal pneumonia in HIV-seropositive and HIV-seronegative adults. Chest. 1999;116:107-114.
15. Nuorti JP, Butler JC, Gelling L, Kool JL, Reingold AL, Vugia DJ, Epidemiologic relation between HIV and invasive pneumococcal disease in San Francisco County, California. Ann Intern Med. 2000;132:182-190.
16. Butler JC, Hofmann J, Cetron MS, Elliott JA, Facklam RR, Breiman RF. The continued emergence of drug-resistant Streptococcus pneumoniae in the United States: an update from the Centers for Disease Control and Prevention's Pneumococcal Sentinel Surveillance System. J Infect Dis. 1996;174:986-993.
17. Winston LG, Perlman JL, Rose DA, Gerberding JL. Penicillin-nonsusceptible Streptococcus pneumoniae at San Francisco General Hospital. Clin Infect Dis. 1999;29:580-585.
18. Albanese BA, Roche JC, Pass M, Whitney CG, McEllistrem MC, Harrison LH, Maryland Emerging Infections Program. Geographic, demographic, and seasonal differences in penicillin-resistant Streptococcus pneumoniae in Baltimore. Clin Infect Dis. 2002;34:15-21.
19. Laffer RR, Frei R, Widmer AF. Epidemiology of septicemias in a university hospital over 5 years [in German]. Schweiz Med Wochenschr. 2000;130:1471-1478.
20. Thorpe TC, Wilson ML, Turner JE, et al. BacT/Alert: an automated colorimetric microbial detection system. J Clin Microbiol. 1990;28:1608-1612.
21. National Committee for Clinical Laboratory Standards. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically. 5th ed. Wayne, Pa: NCCLS; 2000;17:10-13. Publication No. NCCLS M7-A5.
22. Centers for Disease Control and Prevention. Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 1997;46(RR-8):1-24.
23. Giesecke J, Fredlund H. Increase in pneumococcal bacteraemia in Sweden [letter] [published correction appears in Lancet. 1997;349:1106]. Lancet. 1997;349:699-700.
24. Giesecke J, Fredlund H. Increase in pneumococcal bacteraemia in Sweden [letter] [published correction appears in Lancet. 1997;349:1106]. Lancet. 1997;349:699-700.
25. Ekdahl K, Martensson A, Kamme C. Bacteraemic pneumococcal infections in Southern Sweden 1981-96: trends in incidence, mortality, age-distribution, serogroups and penicillin-resistance. Scand J Infect Dis. 1998;30:257-262.
26. Kim PE, Musher DM, Glezen WP, Rodriguez-Barradas MC, Nahm WK, Wright CE. Association of invasive pneumococcal disease with season, atmospheric conditions, air pollution, and the isolation of respiratory viruses. Clin Infect Dis. 1996;22:100-106.
27. Raz R, Elhanan G, Shimoni Z, et al, Israeli Adult Pneumococcal Bacteremia Group. Pneumococcal bacteremia in hospitalized Israeli adults: epidemiology and resistance to penicillin. Clin Infect Dis. 1997;24:1164-1168.
28. Dowell SF, Whitney CG, Wright C, Rose CE Jr, Schuchat A. Seasonal patterns of invasive pneumococcal disease. Emerg Infect Dis. 2003;9:573-579.
29. Kalin M, Ortqvist A, Almela M, et al. Prospective study of prognostic factors in community-acquired bacteremic pneumococcal disease in 5 countries. J Infect Dis. 2000;182:840-847.
30. Moroney JF, Fiore AE, Harrison LH, et al. Clinical outcomes of bacteremic pneumococcal pneumonia in the'era of antibiotic resistance. Clin Infect Dis. 2001;33:797-805.
31. McKenzie H, Reid N, Dijkhuizen RS. Clinical and microbiological epidemiology of Streptococcus pneumoniae bacteraemia. J Med Microbiol. 2000;49:361-366.
32. Yu VL, Chiou CC, Feldman C, et al, International Pneumococcal Study Group. An international prospective study of pneumococcal bacteremia: correlation with in vitro resistance, antibiotics administered, and clinical outcome. Clin Infect Dis. 2003;37:230-237.
33. Lee CY, Chiu CH, Huang YC, et al. Invasive pneumococcal infections: a clinical and microbiological analysis of 53 patients in Taiwan. Clin Microbiol Infect. 2003;9:614-618.
34. Kyaw MH, Christie P, Clarke SC, et al. Invasive pneumococcal disease in Scotland, 1999-2001: use of record linkage to explore associations between patients and disease in relation to future vaccination policy. Clin Infect Dis. 2003;37:1283-1291.
35. Byl B, Clevenbergh P, Jacobs F, et al. Impact of infectious diseases specialists and microbiological data on the appropriateness of antimicrobial therapy for bacteremia. Clin Infect Dis. 1999;29:60-66.
36. Fluckiger U, Zimmerli W, Sax H, Frei R, Widmer AF. Clinical impact of an infectious disease service on the management of bloodstream infection. Eur J Clin Microbiol Infect Dis. 2000;19:493-500.
37. Gransden WR, Eykyn SJ, Phillips I. Pneumococcal bacteraemia: 325 episodes diagnosed at St Thomas's Hospital. Br Med J (Clin Res Ed). 1985;290:505-508.
38. Friedland IR, McCracken GH Jr. Management of infections caused by antibiotic-resistant Streptococcus pneumoniae. N Engl J Med. 1994;331:377-382.
39. Redd SC, Rutherford GW III, Sande MA, et al. The role of human immunodeficiency virus infection in pneumococcal bacteremia in San Francisco residents. J Infect Dis. 1990;162:1012-1017.
40. Garcia-Leoni ME, Moreno S, Rodeno P, Cercenado E, Vicente T, Bouza E. Pneumococcal pneumonia in adult hospitalized patients infected with the human immunodeficiency virus. Arch Intern Med. 1992;152:1808-1812.
41. Pallares R, Linares J. Vadillo M, et al. Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain [published correction appears in N Engl J Med. 1995;333:1655]. N Engl J Med. 1995;333:474-480.
42. Pallares R, Linares J. Vadillo M, et al. Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain [published correction appears in N Engl J Med. 1995;333:1655]. N Engl J Med. 1995;333:474-480.
43. Pesola GR, Charles A. Pneumococcal bacteremia with pneumonia: mortality in acquired immunodeficiency syndrome. Chest. 1992;101:150-155.
44. Haglund LA, Istre GR, Pickett DA, Welch DF, Fine DP, Pneumococcus Study Group. Invasive pueumococcal disease in central Oklahoma: emergence of high-level penicillin resistance and multiple antibiotic resistance. J Infect Dis. 1993;168:1532-1536.
45. Rodriguez-Creixems M, Munoz P, Miranda E, Pelaez T, Alonso R, Bouza E. Recurrent pneumococcal bacteremia: a warning of immunodeficiency. Arch Intern Med. 1996;156:1429-1434.
46. Coccia MR, Facklam RR, Saravolatz LD, Manzor O. Recurrent pneumococcal bacteremia: 34 episodes in 15 patients. Clin Infect Dis. 1998;26:982-985.
47. King MD, Whitney CG, Parekh F, Farley MM, Active Bacterial Core Surveillance Team/Emerging Infections Program Network. Recurrent invasive pneumococcal disease: a population-based assessment. Clin Infect Dis. 2003;37:1029-1036.